The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | Immunotherapy for MPNs: where do we stand?
Bethan Psaila
• 15 Nov 2019
Bethan Psaila, MBBS, MRCP, FRCPath, PhD, University of Oxford, Oxford, UK, gives an overview of where we currently stand with immunotherapy in myeloproliferative neoplasms (MPNs), highlighting an exciting new potential target. This interview took place at the MPN Advances Day 2019 in London, UK.
